2021
DOI: 10.1016/j.jcin.2020.10.001
|View full text |Cite
|
Sign up to set email alerts
|

3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
138
1
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 175 publications
(146 citation statements)
references
References 21 publications
3
138
1
3
Order By: Relevance
“…Evidence suggesting a clinical benefit for using IVUS for PCI guidance has been shown in several registries 94 , randomised trials 4,95 , and meta-analyses 96,97 . In randomised trials, IVUS guidance is associated with a reduction in major adverse cardiac events, and in meta-analyses, with reduced cardiovascular mortality, MI, and stent thrombosis compared with angiography guidance 7 .…”
Section: Oct Versus Ivus Versus Angiography In Registries and Randomised Trialsmentioning
confidence: 99%
“…Evidence suggesting a clinical benefit for using IVUS for PCI guidance has been shown in several registries 94 , randomised trials 4,95 , and meta-analyses 96,97 . In randomised trials, IVUS guidance is associated with a reduction in major adverse cardiac events, and in meta-analyses, with reduced cardiovascular mortality, MI, and stent thrombosis compared with angiography guidance 7 .…”
Section: Oct Versus Ivus Versus Angiography In Registries and Randomised Trialsmentioning
confidence: 99%
“…IVUS during ULMCA PCI is safe and associates with substantial reductions in MACE in the long-term follow up, including repeated revascularization and even death. 15 In conclusion, Grion et al 9 demonstrated very good inhospital results of IVUS-guided complex ULMCA PCI in our environment. Knowing and publicizing our in-hospital results is DOI: https://doi.org/10.36660/abc.20210236…”
mentioning
confidence: 56%
“…Jun-Jie Zhang, MD, PhD, of Nanjing First Hospital, China, presented the 3-year results of the ULTIMATE trial at TCT Connect 2020, which showed a sustained advantage for IVUS that was first reported with the 1-year results, which Zhang presented at TCT 2018 [ 3 ]. The 3-year study results were also simultaneously published online in JACC: Cardiovascular Interventions [ 4 ].…”
Section: Imagingmentioning
confidence: 99%